Medical Marijuana, Inc. MJNA

MJNA Company Overview

Medical Marijuana, Inc. is a U.S.-based cannabis and hemp-focused holding company that develops, markets, and distributes products derived primarily from industrial hemp. The company operates in the broader cannabis wellness, nutraceutical, personal care, and cannabinoid consumer products industries, with a strategic focus on cannabidiol (CBD) and related hemp-derived compounds. Its revenue has historically been driven through the sale of hemp-based dietary supplements, wellness products, cosmetics, and cannabinoid ingredients distributed through subsidiaries and affiliated brands. The company has also pursued licensing, international distribution, and investment activities tied to the legal cannabis and hemp sectors.

The company was founded in 2009 and became one of the earliest publicly traded cannabis-related companies in the United States through over-the-counter markets. Over time, Medical Marijuana, Inc. evolved from a broad cannabis investment and development platform into a holding company centered on hemp-derived consumer products and cannabinoid research initiatives. The company has emphasized early-mover positioning in hemp-derived CBD products, particularly before broader regulatory acceptance in the U.S. market. Public disclosures and corporate filings indicate that the company has focused on brand development, international expansion, and scientific validation of cannabinoid applications.